Baidu
map
J EXTRACELL VESICLES 润色咨询

Journal of Extracellular Vesicles

出版年份：暂无数据 年文章数：779 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2212874, encodeId=c6c022128e409, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：细胞外囊泡;外泌体;肿瘤治疗<br>经验分享：还在投稿中，比较漫长<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b149371362, createdName=ms1000001774634982, createdTime=Tue Jul 02 22:17:11 CST 2024, time=2024-07-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161285, encodeId=57d2216128537, content=为什么最近投了一个月了还没有消息啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a15468942, createdName=ms9000002067712991, createdTime=Sat Oct 07 09:16:28 CST 2023, time=2023-10-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157380, encodeId=9d92215e38040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：外泌体<br>经验分享：再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=802a8265756, createdName=ms7000002143627712, createdTime=Tue Sep 12 17:41:30 CST 2023, time=2023-09-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2189292, encodeId=93c6218929247, content=请问大家都投了多久才有被拒或者送审的消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Feb 25 17:22:18 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=799604, encodeId=bd36e9960439, content=耗时10个月，终于online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2a05288175, createdName=148598a0m80暂无昵称, createdTime=Wed Jun 24 22:22:45 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578281, encodeId=15df5e828135, content=Jev有没有人有投稿经验的，来介绍一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/17/ff7375d1348aa0b0a3457526f63bafc7.jpg, createdBy=434b1927706, createdName=俊十八, createdTime=Tue Oct 22 00:00:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128235, encodeId=651b212823590, content=h h h, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1ef8649677, createdName=ms5000000866339852, createdTime=Tue Apr 25 13:30:00 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097230, encodeId=76ad209e23047, content=同志们，投稿链接在哪里？另外为什么学校邮箱注册不了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cdf02168429, createdName=12048830m36暂无昵称, createdTime=Sat Oct 29 10:41:46 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182850, encodeId=8e881182850b9, content=投稿被退回，告诉我submit the article in S1M 什么是S1M??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqZsQyj5ukNkh8dvwrT3DjM6O9bnCaAS8OGPdh2alqIfWfWwDEbfZl5o0QWOKrT37OiceRRKDsyvFA/132, createdBy=d5b42005232, createdName=ivantang, createdTime=Mon Jan 10 15:02:40 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107487, encodeId=b483110e487ca, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2024-07-02 ms1000001774634982 来自浙江省

    审稿速度:12.0 | 投稿命中率:25.0
    偏重的研究方向：细胞外囊泡;外泌体;肿瘤治疗
    经验分享：还在投稿中，比较漫长

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2212874, encodeId=c6c022128e409, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：细胞外囊泡;外泌体;肿瘤治疗<br>经验分享：还在投稿中，比较漫长<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b149371362, createdName=ms1000001774634982, createdTime=Tue Jul 02 22:17:11 CST 2024, time=2024-07-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161285, encodeId=57d2216128537, content=为什么最近投了一个月了还没有消息啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a15468942, createdName=ms9000002067712991, createdTime=Sat Oct 07 09:16:28 CST 2023, time=2023-10-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157380, encodeId=9d92215e38040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：外泌体<br>经验分享：再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=802a8265756, createdName=ms7000002143627712, createdTime=Tue Sep 12 17:41:30 CST 2023, time=2023-09-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2189292, encodeId=93c6218929247, content=请问大家都投了多久才有被拒或者送审的消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Feb 25 17:22:18 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=799604, encodeId=bd36e9960439, content=耗时10个月，终于online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2a05288175, createdName=148598a0m80暂无昵称, createdTime=Wed Jun 24 22:22:45 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578281, encodeId=15df5e828135, content=Jev有没有人有投稿经验的，来介绍一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/17/ff7375d1348aa0b0a3457526f63bafc7.jpg, createdBy=434b1927706, createdName=俊十八, createdTime=Tue Oct 22 00:00:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128235, encodeId=651b212823590, content=h h h, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1ef8649677, createdName=ms5000000866339852, createdTime=Tue Apr 25 13:30:00 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097230, encodeId=76ad209e23047, content=同志们，投稿链接在哪里？另外为什么学校邮箱注册不了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cdf02168429, createdName=12048830m36暂无昵称, createdTime=Sat Oct 29 10:41:46 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182850, encodeId=8e881182850b9, content=投稿被退回，告诉我submit the article in S1M 什么是S1M??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqZsQyj5ukNkh8dvwrT3DjM6O9bnCaAS8OGPdh2alqIfWfWwDEbfZl5o0QWOKrT37OiceRRKDsyvFA/132, createdBy=d5b42005232, createdName=ivantang, createdTime=Mon Jan 10 15:02:40 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107487, encodeId=b483110e487ca, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-10-07 ms9000002067712991 来自重庆

    为什么最近投了一个月了还没有消息啊

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2212874, encodeId=c6c022128e409, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：细胞外囊泡;外泌体;肿瘤治疗<br>经验分享：还在投稿中，比较漫长<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b149371362, createdName=ms1000001774634982, createdTime=Tue Jul 02 22:17:11 CST 2024, time=2024-07-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161285, encodeId=57d2216128537, content=为什么最近投了一个月了还没有消息啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a15468942, createdName=ms9000002067712991, createdTime=Sat Oct 07 09:16:28 CST 2023, time=2023-10-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157380, encodeId=9d92215e38040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：外泌体<br>经验分享：再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=802a8265756, createdName=ms7000002143627712, createdTime=Tue Sep 12 17:41:30 CST 2023, time=2023-09-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2189292, encodeId=93c6218929247, content=请问大家都投了多久才有被拒或者送审的消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Feb 25 17:22:18 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=799604, encodeId=bd36e9960439, content=耗时10个月，终于online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2a05288175, createdName=148598a0m80暂无昵称, createdTime=Wed Jun 24 22:22:45 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578281, encodeId=15df5e828135, content=Jev有没有人有投稿经验的，来介绍一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/17/ff7375d1348aa0b0a3457526f63bafc7.jpg, createdBy=434b1927706, createdName=俊十八, createdTime=Tue Oct 22 00:00:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128235, encodeId=651b212823590, content=h h h, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1ef8649677, createdName=ms5000000866339852, createdTime=Tue Apr 25 13:30:00 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097230, encodeId=76ad209e23047, content=同志们，投稿链接在哪里？另外为什么学校邮箱注册不了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cdf02168429, createdName=12048830m36暂无昵称, createdTime=Sat Oct 29 10:41:46 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182850, encodeId=8e881182850b9, content=投稿被退回，告诉我submit the article in S1M 什么是S1M??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqZsQyj5ukNkh8dvwrT3DjM6O9bnCaAS8OGPdh2alqIfWfWwDEbfZl5o0QWOKrT37OiceRRKDsyvFA/132, createdBy=d5b42005232, createdName=ivantang, createdTime=Mon Jan 10 15:02:40 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107487, encodeId=b483110e487ca, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-09-12 ms7000002143627712 来自辽宁省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向：外泌体
    经验分享：再投

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2212874, encodeId=c6c022128e409, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：细胞外囊泡;外泌体;肿瘤治疗<br>经验分享：还在投稿中，比较漫长<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b149371362, createdName=ms1000001774634982, createdTime=Tue Jul 02 22:17:11 CST 2024, time=2024-07-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161285, encodeId=57d2216128537, content=为什么最近投了一个月了还没有消息啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a15468942, createdName=ms9000002067712991, createdTime=Sat Oct 07 09:16:28 CST 2023, time=2023-10-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157380, encodeId=9d92215e38040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：外泌体<br>经验分享：再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=802a8265756, createdName=ms7000002143627712, createdTime=Tue Sep 12 17:41:30 CST 2023, time=2023-09-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2189292, encodeId=93c6218929247, content=请问大家都投了多久才有被拒或者送审的消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Feb 25 17:22:18 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=799604, encodeId=bd36e9960439, content=耗时10个月，终于online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2a05288175, createdName=148598a0m80暂无昵称, createdTime=Wed Jun 24 22:22:45 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578281, encodeId=15df5e828135, content=Jev有没有人有投稿经验的，来介绍一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/17/ff7375d1348aa0b0a3457526f63bafc7.jpg, createdBy=434b1927706, createdName=俊十八, createdTime=Tue Oct 22 00:00:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128235, encodeId=651b212823590, content=h h h, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1ef8649677, createdName=ms5000000866339852, createdTime=Tue Apr 25 13:30:00 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097230, encodeId=76ad209e23047, content=同志们，投稿链接在哪里？另外为什么学校邮箱注册不了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cdf02168429, createdName=12048830m36暂无昵称, createdTime=Sat Oct 29 10:41:46 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182850, encodeId=8e881182850b9, content=投稿被退回，告诉我submit the article in S1M 什么是S1M??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqZsQyj5ukNkh8dvwrT3DjM6O9bnCaAS8OGPdh2alqIfWfWwDEbfZl5o0QWOKrT37OiceRRKDsyvFA/132, createdBy=d5b42005232, createdName=ivantang, createdTime=Mon Jan 10 15:02:40 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107487, encodeId=b483110e487ca, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2024-02-25 wkw0722 来自山东省

    请问大家都投了多久才有被拒或者送审的消息啊？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2212874, encodeId=c6c022128e409, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：细胞外囊泡;外泌体;肿瘤治疗<br>经验分享：还在投稿中，比较漫长<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b149371362, createdName=ms1000001774634982, createdTime=Tue Jul 02 22:17:11 CST 2024, time=2024-07-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161285, encodeId=57d2216128537, content=为什么最近投了一个月了还没有消息啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a15468942, createdName=ms9000002067712991, createdTime=Sat Oct 07 09:16:28 CST 2023, time=2023-10-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157380, encodeId=9d92215e38040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：外泌体<br>经验分享：再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=802a8265756, createdName=ms7000002143627712, createdTime=Tue Sep 12 17:41:30 CST 2023, time=2023-09-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2189292, encodeId=93c6218929247, content=请问大家都投了多久才有被拒或者送审的消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Feb 25 17:22:18 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=799604, encodeId=bd36e9960439, content=耗时10个月，终于online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2a05288175, createdName=148598a0m80暂无昵称, createdTime=Wed Jun 24 22:22:45 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578281, encodeId=15df5e828135, content=Jev有没有人有投稿经验的，来介绍一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/17/ff7375d1348aa0b0a3457526f63bafc7.jpg, createdBy=434b1927706, createdName=俊十八, createdTime=Tue Oct 22 00:00:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128235, encodeId=651b212823590, content=h h h, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1ef8649677, createdName=ms5000000866339852, createdTime=Tue Apr 25 13:30:00 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097230, encodeId=76ad209e23047, content=同志们，投稿链接在哪里？另外为什么学校邮箱注册不了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cdf02168429, createdName=12048830m36暂无昵称, createdTime=Sat Oct 29 10:41:46 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182850, encodeId=8e881182850b9, content=投稿被退回，告诉我submit the article in S1M 什么是S1M??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqZsQyj5ukNkh8dvwrT3DjM6O9bnCaAS8OGPdh2alqIfWfWwDEbfZl5o0QWOKrT37OiceRRKDsyvFA/132, createdBy=d5b42005232, createdName=ivantang, createdTime=Mon Jan 10 15:02:40 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107487, encodeId=b483110e487ca, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2020-06-24 148598a0m80暂无昵称

    耗时10个月，终于online

    8

    展开8条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2212874, encodeId=c6c022128e409, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：细胞外囊泡;外泌体;肿瘤治疗<br>经验分享：还在投稿中，比较漫长<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b149371362, createdName=ms1000001774634982, createdTime=Tue Jul 02 22:17:11 CST 2024, time=2024-07-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161285, encodeId=57d2216128537, content=为什么最近投了一个月了还没有消息啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a15468942, createdName=ms9000002067712991, createdTime=Sat Oct 07 09:16:28 CST 2023, time=2023-10-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157380, encodeId=9d92215e38040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：外泌体<br>经验分享：再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=802a8265756, createdName=ms7000002143627712, createdTime=Tue Sep 12 17:41:30 CST 2023, time=2023-09-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2189292, encodeId=93c6218929247, content=请问大家都投了多久才有被拒或者送审的消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Feb 25 17:22:18 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=799604, encodeId=bd36e9960439, content=耗时10个月，终于online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2a05288175, createdName=148598a0m80暂无昵称, createdTime=Wed Jun 24 22:22:45 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578281, encodeId=15df5e828135, content=Jev有没有人有投稿经验的，来介绍一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/17/ff7375d1348aa0b0a3457526f63bafc7.jpg, createdBy=434b1927706, createdName=俊十八, createdTime=Tue Oct 22 00:00:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128235, encodeId=651b212823590, content=h h h, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1ef8649677, createdName=ms5000000866339852, createdTime=Tue Apr 25 13:30:00 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097230, encodeId=76ad209e23047, content=同志们，投稿链接在哪里？另外为什么学校邮箱注册不了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cdf02168429, createdName=12048830m36暂无昵称, createdTime=Sat Oct 29 10:41:46 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182850, encodeId=8e881182850b9, content=投稿被退回，告诉我submit the article in S1M 什么是S1M??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqZsQyj5ukNkh8dvwrT3DjM6O9bnCaAS8OGPdh2alqIfWfWwDEbfZl5o0QWOKrT37OiceRRKDsyvFA/132, createdBy=d5b42005232, createdName=ivantang, createdTime=Mon Jan 10 15:02:40 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107487, encodeId=b483110e487ca, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2019-10-22 俊十八

    Jev有没有人有投稿经验的，来介绍一下

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2212874, encodeId=c6c022128e409, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：细胞外囊泡;外泌体;肿瘤治疗<br>经验分享：还在投稿中，比较漫长<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b149371362, createdName=ms1000001774634982, createdTime=Tue Jul 02 22:17:11 CST 2024, time=2024-07-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161285, encodeId=57d2216128537, content=为什么最近投了一个月了还没有消息啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a15468942, createdName=ms9000002067712991, createdTime=Sat Oct 07 09:16:28 CST 2023, time=2023-10-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157380, encodeId=9d92215e38040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：外泌体<br>经验分享：再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=802a8265756, createdName=ms7000002143627712, createdTime=Tue Sep 12 17:41:30 CST 2023, time=2023-09-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2189292, encodeId=93c6218929247, content=请问大家都投了多久才有被拒或者送审的消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Feb 25 17:22:18 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=799604, encodeId=bd36e9960439, content=耗时10个月，终于online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2a05288175, createdName=148598a0m80暂无昵称, createdTime=Wed Jun 24 22:22:45 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578281, encodeId=15df5e828135, content=Jev有没有人有投稿经验的，来介绍一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/17/ff7375d1348aa0b0a3457526f63bafc7.jpg, createdBy=434b1927706, createdName=俊十八, createdTime=Tue Oct 22 00:00:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128235, encodeId=651b212823590, content=h h h, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1ef8649677, createdName=ms5000000866339852, createdTime=Tue Apr 25 13:30:00 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097230, encodeId=76ad209e23047, content=同志们，投稿链接在哪里？另外为什么学校邮箱注册不了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cdf02168429, createdName=12048830m36暂无昵称, createdTime=Sat Oct 29 10:41:46 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182850, encodeId=8e881182850b9, content=投稿被退回，告诉我submit the article in S1M 什么是S1M??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqZsQyj5ukNkh8dvwrT3DjM6O9bnCaAS8OGPdh2alqIfWfWwDEbfZl5o0QWOKrT37OiceRRKDsyvFA/132, createdBy=d5b42005232, createdName=ivantang, createdTime=Mon Jan 10 15:02:40 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107487, encodeId=b483110e487ca, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-04-25 ms5000000866339852 来自辽宁省

    h h h

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2212874, encodeId=c6c022128e409, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：细胞外囊泡;外泌体;肿瘤治疗<br>经验分享：还在投稿中，比较漫长<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b149371362, createdName=ms1000001774634982, createdTime=Tue Jul 02 22:17:11 CST 2024, time=2024-07-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161285, encodeId=57d2216128537, content=为什么最近投了一个月了还没有消息啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a15468942, createdName=ms9000002067712991, createdTime=Sat Oct 07 09:16:28 CST 2023, time=2023-10-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157380, encodeId=9d92215e38040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：外泌体<br>经验分享：再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=802a8265756, createdName=ms7000002143627712, createdTime=Tue Sep 12 17:41:30 CST 2023, time=2023-09-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2189292, encodeId=93c6218929247, content=请问大家都投了多久才有被拒或者送审的消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Feb 25 17:22:18 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=799604, encodeId=bd36e9960439, content=耗时10个月，终于online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2a05288175, createdName=148598a0m80暂无昵称, createdTime=Wed Jun 24 22:22:45 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578281, encodeId=15df5e828135, content=Jev有没有人有投稿经验的，来介绍一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/17/ff7375d1348aa0b0a3457526f63bafc7.jpg, createdBy=434b1927706, createdName=俊十八, createdTime=Tue Oct 22 00:00:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128235, encodeId=651b212823590, content=h h h, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1ef8649677, createdName=ms5000000866339852, createdTime=Tue Apr 25 13:30:00 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097230, encodeId=76ad209e23047, content=同志们，投稿链接在哪里？另外为什么学校邮箱注册不了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cdf02168429, createdName=12048830m36暂无昵称, createdTime=Sat Oct 29 10:41:46 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182850, encodeId=8e881182850b9, content=投稿被退回，告诉我submit the article in S1M 什么是S1M??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqZsQyj5ukNkh8dvwrT3DjM6O9bnCaAS8OGPdh2alqIfWfWwDEbfZl5o0QWOKrT37OiceRRKDsyvFA/132, createdBy=d5b42005232, createdName=ivantang, createdTime=Mon Jan 10 15:02:40 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107487, encodeId=b483110e487ca, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-10-29 12048830m36暂无昵称

    同志们，投稿链接在哪里？另外为什么学校邮箱注册不了？

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2212874, encodeId=c6c022128e409, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：细胞外囊泡;外泌体;肿瘤治疗<br>经验分享：还在投稿中，比较漫长<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b149371362, createdName=ms1000001774634982, createdTime=Tue Jul 02 22:17:11 CST 2024, time=2024-07-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161285, encodeId=57d2216128537, content=为什么最近投了一个月了还没有消息啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a15468942, createdName=ms9000002067712991, createdTime=Sat Oct 07 09:16:28 CST 2023, time=2023-10-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157380, encodeId=9d92215e38040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：外泌体<br>经验分享：再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=802a8265756, createdName=ms7000002143627712, createdTime=Tue Sep 12 17:41:30 CST 2023, time=2023-09-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2189292, encodeId=93c6218929247, content=请问大家都投了多久才有被拒或者送审的消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Feb 25 17:22:18 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=799604, encodeId=bd36e9960439, content=耗时10个月，终于online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2a05288175, createdName=148598a0m80暂无昵称, createdTime=Wed Jun 24 22:22:45 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578281, encodeId=15df5e828135, content=Jev有没有人有投稿经验的，来介绍一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/17/ff7375d1348aa0b0a3457526f63bafc7.jpg, createdBy=434b1927706, createdName=俊十八, createdTime=Tue Oct 22 00:00:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128235, encodeId=651b212823590, content=h h h, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1ef8649677, createdName=ms5000000866339852, createdTime=Tue Apr 25 13:30:00 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097230, encodeId=76ad209e23047, content=同志们，投稿链接在哪里？另外为什么学校邮箱注册不了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cdf02168429, createdName=12048830m36暂无昵称, createdTime=Sat Oct 29 10:41:46 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182850, encodeId=8e881182850b9, content=投稿被退回，告诉我submit the article in S1M 什么是S1M??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqZsQyj5ukNkh8dvwrT3DjM6O9bnCaAS8OGPdh2alqIfWfWwDEbfZl5o0QWOKrT37OiceRRKDsyvFA/132, createdBy=d5b42005232, createdName=ivantang, createdTime=Mon Jan 10 15:02:40 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107487, encodeId=b483110e487ca, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-01-10 ivantang

    投稿被退回，告诉我submit the article in S1M 什么是S1M??

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2212874, encodeId=c6c022128e409, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：细胞外囊泡;外泌体;肿瘤治疗<br>经验分享：还在投稿中，比较漫长<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b149371362, createdName=ms1000001774634982, createdTime=Tue Jul 02 22:17:11 CST 2024, time=2024-07-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161285, encodeId=57d2216128537, content=为什么最近投了一个月了还没有消息啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a15468942, createdName=ms9000002067712991, createdTime=Sat Oct 07 09:16:28 CST 2023, time=2023-10-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2157380, encodeId=9d92215e38040, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：外泌体<br>经验分享：再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=802a8265756, createdName=ms7000002143627712, createdTime=Tue Sep 12 17:41:30 CST 2023, time=2023-09-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2189292, encodeId=93c6218929247, content=请问大家都投了多久才有被拒或者送审的消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Feb 25 17:22:18 CST 2024, time=2024-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=799604, encodeId=bd36e9960439, content=耗时10个月，终于online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2a05288175, createdName=148598a0m80暂无昵称, createdTime=Wed Jun 24 22:22:45 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578281, encodeId=15df5e828135, content=Jev有没有人有投稿经验的，来介绍一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/17/ff7375d1348aa0b0a3457526f63bafc7.jpg, createdBy=434b1927706, createdName=俊十八, createdTime=Tue Oct 22 00:00:00 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128235, encodeId=651b212823590, content=h h h, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1ef8649677, createdName=ms5000000866339852, createdTime=Tue Apr 25 13:30:00 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097230, encodeId=76ad209e23047, content=同志们，投稿链接在哪里？另外为什么学校邮箱注册不了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cdf02168429, createdName=12048830m36暂无昵称, createdTime=Sat Oct 29 10:41:46 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182850, encodeId=8e881182850b9, content=投稿被退回，告诉我submit the article in S1M 什么是S1M??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqZsQyj5ukNkh8dvwrT3DjM6O9bnCaAS8OGPdh2alqIfWfWwDEbfZl5o0QWOKrT37OiceRRKDsyvFA/132, createdBy=d5b42005232, createdName=ivantang, createdTime=Mon Jan 10 15:02:40 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107487, encodeId=b483110e487ca, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 MS68862005

    什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？

    1

    展开1条回复
共38条页码: 1/4页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map